You're assuming whoever tweeted that is correct. Here's one of the 189 trials. Perhaps it was in the non-daclatasvir arm. I don't recall cardiovascular issues being a side effect of ribavarin.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.